Robert Kirkman
Overview
Robert Kirkman received an average of $1M in total compensation, including $334K in salary, at Oncothyreon from 2006 to 2016. Robert Kirkman also received $388K at Cyclacel Pharmaceuticals in 2006.
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
OncothyreonFormer President, Chief Executive Officer and Director
OncothyreonFormer President, Chief Executive Officer and Director
OncothyreonFormer President, Chief Executive Officer and Director
OncothyreonFormer President, Chief Executive Officer and Director
OncothyreonPresident, Chief Executive Officer and Director
OncothyreonPresident, Chief Executive Officer and Director
OncothyreonPresident, Chief Executive Officer and Director
OncothyreonPresident, Chief Executive Officer and Director
OncothyreonPresident, Chief Executive Officer and Director
OncothyreonPresident, Chief Executive Officer and Director
Source: SEC filings on April 26, 2017, May 6, 2016, April 23, 2015, April 24, 2014, April 26, 2013, April 24, 2012, April 26, 2011, May 13, 2010, April 5, 2007, and April 29, 2008.
Related executives
We found 20 more executives who work or worked at Oncothyreon and Cyclacel Pharmaceuticals.
Spiro Rombotis
Cyclacel Pharmaceuticals
Chief Executive Officer
Mark Kirschbaum
Cyclacel Pharmaceuticals
Chief Medical Officer
Paul McBarron
Cyclacel Pharmaceuticals
Chief Financial Officer
Judy Chiao
Cyclacel Pharmaceuticals
Vice President, Clinical Development and Regulatory Affairs
Scott Myers
Oncothyreon
Chief Executive Officer
Scott Peterson
Oncothyreon
Chief Scientific Officer
Julia Eastland
Oncothyreon
Chief Financial Officer
Gary Christianson
Oncothyreon